Families Taking Control (FTC): Family-based Problem-solving Intervention for Children With Sickle Cell Disease (FTC)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02273310 |
Recruitment Status :
Completed
First Posted : October 23, 2014
Results First Posted : January 7, 2016
Last Update Posted : January 7, 2016
|
Sponsor:
University of Pennsylvania
Collaborators:
Drexel University
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
University of Pennsylvania
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: None (Open Label); Primary Purpose: Prevention |
Condition |
Sickle Cell Disease |
Intervention |
Behavioral: Problem-Solving Skills Training for Disease Management |
Enrollment | 83 |
Participant Flow
Recruitment Details | |
Pre-assignment Details |
Arm/Group Title | Families Taking Control | Delayed Intervention Control |
---|---|---|
![]() |
Families participate in a 1 day problem solving skills training intervention Problem Solving Training for Disease Management |
Families are given the opportunity to complete the problem solving skills training intervention after assessment time 2. |
Period Title: Overall Study | ||
Started | 42 | 41 |
Completed | 24 | 38 |
Not Completed | 18 | 3 |
Baseline Characteristics
Arm/Group Title | Families Taking Control | Delayed Intervention Control | Total | |
---|---|---|---|---|
![]() |
Families participate in a 1 day problem solving skills training intervention Problem Solving Training for Disease Management |
Families are given the opportunity to complete the problem solving skills training intervention after assessment time 2. | Total of all reporting groups | |
Overall Number of Baseline Participants | 42 | 41 | 83 | |
![]() |
[Not Specified]
|
|||
Age, Continuous
Mean (Standard Deviation) Unit of measure: Years |
||||
Number Analyzed | 42 participants | 41 participants | 83 participants | |
8.29 (2.12) | 8.66 (2.10) | 8.47 (2.11) | ||
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 42 participants | 41 participants | 83 participants | |
Female |
21 50.0%
|
20 48.8%
|
41 49.4%
|
|
Male |
21 50.0%
|
21 51.2%
|
42 50.6%
|
|
Region of Enrollment
Measure Type: Number Unit of measure: Participants |
||||
United States | Number Analyzed | 42 participants | 41 participants | 83 participants |
42 | 41 | 83 |
Outcome Measures
Adverse Events
Limitations and Caveats
[Not Specified]
More Information
Results Point of Contact
Name/Title: | Lamia Barakat, Ph.D. |
Organization: | The Children's Hospital of Philadelphia/Perleman School of Medicine of The University of Pennsylvania |
Phone: | 267-426-8135 |
EMail: | barakat@email.chop.edu |
Responsible Party: | University of Pennsylvania |
ClinicalTrials.gov Identifier: | NCT02273310 |
Other Study ID Numbers: |
U54HL070585 ( U.S. NIH Grant/Contract ) U54HL070585 ( U.S. NIH Grant/Contract ) |
First Submitted: | October 21, 2014 |
First Posted: | October 23, 2014 |
Results First Submitted: | October 29, 2014 |
Results First Posted: | January 7, 2016 |
Last Update Posted: | January 7, 2016 |